Cargando…

The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe

BACKGROUND: After sertindole's suspension, health authorities established a specific named-patient use (NPU) programme in order to supply sertindole to patients who did not respond to or did not tolerate alternative treatments. This programme provided the possibility of prospectively following...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lançon, Christophe, Toumi, Mondher, Sapin, Christophe, Hansen, Karina
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496904/ https://www.ncbi.nlm.nih.gov/pubmed/18638382 http://dx.doi.org/10.1186/1471-244X-8-57

Ejemplares similares

Evaluation of patients on sertindole treatment after failure of other antipsychotics: A retrospective analysis
por: Azorin, Jean-Michel, et al.
Publicado: (2008)

Sertindole in the Management of Schizophrenia
por: Juruena, Mario F., et al.
Publicado: (2011)

Emerging role of sertindole in the management of schizophrenia
por: Cincotta, Stephanie L, et al.
Publicado: (2010)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Emerging treatments in the management of schizophrenia – focus on sertindole
por: Muscatello, Maria Rosaria A, et al.
Publicado: (2010)

Identification and synthesis of impurities formed during sertindole preparation
por: Sunil Kumar, I V, et al.
Publicado: (2011)

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023)

Antibacterial and Antibiofilm Activities of Sertindole and Its Antibacterial Mechanism against Staphylococcus aureus
por: Tang, Yuanyuan, et al.
Publicado: (2023)

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Gene therapy randomised clinical trials in Europe – a review paper of methodology and design
por: Ilieva, Krassimira, et al.
Publicado: (2020)

A comparative study of orphan drug prices in Europe
por: Young, Katherine Eve, et al.
Publicado: (2017)

Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats
por: Nikiforuk, Agnieszka, et al.
Publicado: (2011)

Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram
por: Llorca, Pierre-Michel, et al.
Publicado: (2015)

Health related quality of life in patients having schizophrenia negative symptoms – a systematic review
por: Azaiez, Chiraz, et al.
Publicado: (2018)

Key drivers for market penetration of biosimilars in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2017)

Overview of external reference pricing systems in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2015)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles
por: Yoon, Yi-Seul, et al.
Publicado: (2020)

Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe
por: Monleón, Clara, et al.
Publicado: (2022)

Calling Names
por: Bernard, Christophe
Publicado: (2020)

Photodegradation Study of Sertindole by UHPLC-ESI-Q-TOF and Influence of Some Metal Oxide Excipients on the Degradation Process
por: Trawiński, Jakub, et al.
Publicado: (2019)

PM450. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice
por: Ulak, Guner, et al.
Publicado: (2016)

The Antipsychotic Agent Sertindole Exhibited Antiproliferative Activities by Inhibiting the STAT3 Signaling Pathway in Human Gastric Cancer Cells
por: Dai, Chunyan, et al.
Publicado: (2020)

The Market Access Society launches a new journal
por: Toumi, Mondher
Publicado: (2013)

Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases
por: Zhang, Wei, et al.
Publicado: (2018)

Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France
por: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
Publicado: (2013)

Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro
por: Hsu, Chao-Yu, et al.
Publicado: (2023)

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting
por: François, Clément, et al.
Publicado: (2017)

Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
por: Medic, Goran, et al.
Publicado: (2017)

Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA
por: Aballéa, Samuel, et al.
Publicado: (2013)

Benefits of probabilistic sensitivity analysis – a review of NICE decisions
por: Adalsteinsson, Erpur, et al.
Publicado: (2013)

Replacement names and nomenclatural comments for problematic species-group names in Europe's Neogene freshwater Gastropoda. Part 2
por: Neubauer, Thomas A., et al.
Publicado: (2014)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey
por: Angermeyer, Matthias C, et al.
Publicado: (2013)

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis
por: Toumi, Mondher, et al.
Publicado: (2014)

National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning
por: Ricciardi, Walter, et al.
Publicado: (2015)

Introduction
por: Toumi, Mondher, et al.
Publicado: (2015)

Economic and health implications from earlier detection of HIV infection in the United Kingdom
por: Zah, Vladimir, et al.
Publicado: (2016)

Non-profit drug research and development: the case study of Genethon
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Value added medicines: what value repurposed medicines might bring to society?
por: Toumi, Mondher, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8gh20q5mc5hk2j1m2r0k37vjo